1. Home
  2. BGSI vs CORT Comparison

BGSI vs CORT Comparison

Compare BGSI & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BGSI

Boyd Group Services Inc.

N/A

Current Price

$122.19

Market Cap

3.5B

Sector

N/A

ML Signal

N/A

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

N/A

Current Price

$51.75

Market Cap

3.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BGSI
CORT
Founded
1990
1998
Country
Canada
United States
Employees
13449
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.7B
IPO Year
N/A
2001

Fundamental Metrics

Financial Performance
Metric
BGSI
CORT
Price
$122.19
$51.75
Analyst Decision
Buy
Buy
Analyst Count
1
5
Target Price
$157.00
$96.50
AVG Volume (30 Days)
22.6K
981.4K
Earning Date
05-13-2026
04-30-2026
Dividend Yield
0.38%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$761,407,000.00
Revenue This Year
$35.07
$26.08
Revenue Next Year
$8.01
$26.98
P/E Ratio
$231.07
N/A
Revenue Growth
N/A
12.79
52 Week Low
$115.40
$28.66
52 Week High
$183.10
$91.00

Technical Indicators

Market Signals
Indicator
BGSI
CORT
Relative Strength Index (RSI) 42.34 74.24
Support Level $116.17 $32.95
Resistance Level $131.30 $75.20
Average True Range (ATR) 3.80 1.93
MACD 1.45 0.41
Stochastic Oscillator 41.58 85.11

Price Performance

Historical Comparison
BGSI
CORT

About BGSI Boyd Group Services Inc.

Boyd Group Services Inc is engaged in operating non-franchised collision repair centers in North America. The Company's primary line of business is automotive collision and glass repair and related services, with the majority of revenues relating to this group of similar services. This line of business operates in Canada and the U.S. and both regions exhibit similar long-term economic characteristics. he Company is also a retail auto glass operator in the United States, under the trade names Gerber Collision & Glass, Glass America, Auto Glass Service, Auto Glass Authority. The company has majority of its sales from USA.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

Share on Social Networks: